Profiling Human Cerebrospinal Fluid (CSF) Endogenous Peptidome in Alzheimer's Disease
Danqing Wang1, Zhengwei Chen1, Lingjun Li2,3
1Department of Chemistry, University of Wisconsin-Madison, Madison, WI, USA.
None:
Human cerebrospinal fluid (CSF) is a rich source for central nervous system (CNS)-related disease biomarker discovery due to its direct interchange with the extracellular fluid of the CNS. Though extensive proteome-level profiling has been conducted for CSF, studies targeting at its endogenous peptidome is still limited. It is more difficult to include the post-translational modifications (PTMs) characterization of the peptidome in the mass spectrometry (MS) analysis because of their low abundance and the challenge of data interpretation. In this chapter, we present a peptidomic workflow that combines molecular weight cut-off (MWCO) separation, electron-transfer and higher-energy collision dissociation (EThcD) fragmentation, and a three-step database searching strategy for comprehensive PTM analysis of endogenous peptides including both N-glycosylation and O-glycosylation and other common peptide PTMs. The method has been successfully adopted to analyze CSF samples from healthy donors, mild cognitive impairment (MCI), and Alzheimer's disease (AD) patients to provide a landscape of peptidome in different disease states.
More Related Videos
Related Concept Videos
Anatomy of the Brain: Ventricles
Cerebrospinal Fluid
CSF Production
CSF is produced mainly in the choroid plexus, a network of capillaries and ependymal cells located within the ventricular system of the brain....
Hemorrhagic Stroke l: Introduction
Brain Abscess l: Introduction
Cerebral Edema l: Introduction
Cerebral Edema ll: Pathophysiology


